Skip to main content

Advertisement

Table 2 Characteristics of the diagnosis part of included studies

From: Prognostic and diagnostic significance of galectins in pancreatic cancer: a systematic review and meta-analysis

StudyRegionGalectin typePatientControlTPFPFNTNCutoff valueSample sourceDetection method
NumberAge (M)Sex (M/F)PathologyStageNumberAge (M)Sex (M/F)
Xie [22]ChinaGalactin-349NRNRPDACTNM I–IV88NRNR37812803.77 ng/mlSerumImmunoassay
Coppin [23]FranceGalactin-34464 (41–82)22/22PDATNM I–IV5860 (41–89)42/161225323323.6 ng/ml (male), 27.2 ng/ml (female)SerumImmunoassay
Shimura [24]JapanGalactin-3216714/7PCTNM I-III3555 (25–84)20/1518143216.2 ng/mlSerumImmunoassay
Liao [25]TaiwanGalactin-3916358/33PCTNM I–IV915970/21611630756.5 ng/mlSerumImmunoassay